{"id":"https://openalex.org/W2318342106","doi":"https://doi.org/10.1055/s-0032-1313491","title":"BRCA1-defiziente Brusttumoren sind von einer EZH2-Expression abh\u00e4ngig und sensitiv gegen\u00fcber dem Polycomb Repressive Complex 2-Inhibitor 3-deazaneplanocin A","display_name":"BRCA1-defiziente Brusttumoren sind von einer EZH2-Expression abh\u00e4ngig und sensitiv gegen\u00fcber dem Polycomb Repressive Complex 2-Inhibitor 3-deazaneplanocin A","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W2318342106","doi":"https://doi.org/10.1055/s-0032-1313491","mag":"2318342106"},"language":"de","primary_location":{"id":"doi:10.1055/s-0032-1313491","doi":"https://doi.org/10.1055/s-0032-1313491","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0032-1313491","pdf_url":null,"source":{"id":"https://openalex.org/S4210169716","display_name":"Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie","issn_l":"1611-6453","issn":["1611-6453","1611-647X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067564695","display_name":"Julian Puppe","orcid":"https://orcid.org/0000-0001-6005-9491","observed_orcids":["https://orcid.org/0000-0001-6005-9491"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J Puppe","raw_affiliation_strings":["Uniklinik K\u00f6ln, Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe, K\u00f6ln, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uniklinik K\u00f6ln, Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe, K\u00f6ln, Deutschland","institution_ids":["https://openalex.org/I4210153755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035972976","display_name":"Rinske Drost","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R Drost","raw_affiliation_strings":["Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035573799","display_name":"X Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"X Liu","raw_affiliation_strings":["Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021935977","display_name":"SA Joosse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"SA Joosse","raw_affiliation_strings":["Netherlands Cancer Institute, Department of Experimental Therapy, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Department of Experimental Therapy, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B Evers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"B Evers","raw_affiliation_strings":["Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079501701","display_name":"Petra M. Nederlof","orcid":"https://orcid.org/0000-0002-2358-9765","observed_orcids":["https://orcid.org/0000-0002-2358-9765"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P Nederlof","raw_affiliation_strings":["Netherlands Cancer Institute, Department of Pathology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Department of Pathology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Q Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66068411","display_name":"Genome Institute of Singapore","ror":"https://ror.org/05k8wg936","country_code":"SG","type":"facility","lineage":["https://openalex.org/I115228651","https://openalex.org/I2801752549","https://openalex.org/I66068411"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Q Yu","raw_affiliation_strings":["Genome Institute of Singapore, Molecular Pharmacology, Singapur, Singapur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genome Institute of Singapore, Molecular Pharmacology, Singapur, Singapur","institution_ids":["https://openalex.org/I66068411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061340130","display_name":"Jos Jonkers","orcid":"https://orcid.org/0000-0002-9264-9792","observed_orcids":["https://orcid.org/0000-0002-9264-9792"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J Jonkers","raw_affiliation_strings":["Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Division of Molecular Biology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063380198","display_name":"Maarten van Lohuizen","orcid":"https://orcid.org/0000-0001-6877-2873","observed_orcids":["https://orcid.org/0000-0001-6877-2873"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M van Lohuizen","raw_affiliation_strings":["Netherlands Cancer Institute, Molecular Genetics and Cancer Genomics Centre, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Molecular Genetics and Cancer Genomics Centre, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074526741","display_name":"AM Pietersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165932596","display_name":"National University of Singapore","ror":"https://ror.org/01tgyzw49","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596"]},{"id":"https://openalex.org/I4210126319","display_name":"Duke-NUS Medical School","ror":"https://ror.org/02j1m6098","country_code":"SG","type":"education","lineage":["https://openalex.org/I165932596","https://openalex.org/I170897317","https://openalex.org/I4210126319"]},{"id":"https://openalex.org/I4210137145","display_name":"National Cancer Centre Singapore","ror":"https://ror.org/03bqk3e80","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I4210137145"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"AM Pietersen","raw_affiliation_strings":["Duke-NUS GMS, National Cancer Centre, Singapur, Singapur"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke-NUS GMS, National Cancer Centre, Singapur, Singapur","institution_ids":["https://openalex.org/I165932596","https://openalex.org/I4210126319","https://openalex.org/I4210137145"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003246186","display_name":"Peter K Mallmann","orcid":"https://orcid.org/0000-0001-5612-9733","observed_orcids":["https://orcid.org/0000-0001-5612-9733"]},"institutions":[{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P Mallmann","raw_affiliation_strings":["Uniklinik K\u00f6ln, Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe, K\u00f6ln, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uniklinik K\u00f6ln, Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe, K\u00f6ln, Deutschland","institution_ids":["https://openalex.org/I4210153755"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18719212,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"02","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.1881999969482422,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.15600000321865082,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brca1-deficiency","display_name":"BRCA1 deficiency","score":0.8629999756813049},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/polycomb-repressive-complex-2","display_name":"polycomb repressive complex 2","score":0.9120000004768372},{"id":"https://openalex.org/keywords/dznep","display_name":"DZNep","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ezh2-inhibitors","display_name":"EZH2 inhibitors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/basal-like-breast-cancer","display_name":"basal-like breast cancer","score":0.6660000085830688},{"id":"https://openalex.org/keywords/gene-repression","display_name":"gene repression","score":0.5199999809265137},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.5709999799728394},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5759999752044678},{"id":"https://openalex.org/keywords/brca1-mutation-carriers","display_name":"BRCA1 mutation carriers","score":0.6800000071525574},{"id":"https://openalex.org/keywords/tumor-differentiation","display_name":"tumor differentiation","score":0.3449999988079071},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.38999998569488525}],"concepts":[{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.49557745456695557},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3592129051685333}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-0032-1313491","doi":"https://doi.org/10.1055/s-0032-1313491","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0032-1313491","pdf_url":null,"source":{"id":"https://openalex.org/S4210169716","display_name":"Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie","issn_l":"1611-6453","issn":["1611-6453","1611-647X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Senologie - Zeitschrift f\u00fcr Mammadiagnostik und -therapie","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133743991","https://openalex.org/W2612007315","https://openalex.org/W2942776126","https://openalex.org/W7055791429","https://openalex.org/W2531671966","https://openalex.org/W2315677086","https://openalex.org/W2013011831","https://openalex.org/W2107966374","https://openalex.org/W2977747291","https://openalex.org/W1965161305"],"abstract_inverted_index":{"Zielsetzung:":[0],"Brustkrebs":[1,48],"ist":[2,126],"eine":[3,33,87,134,198,224,235,238],"heterogene":[4],"Erkrankung":[5],"und":[6,25,40,58],"die":[7,65,115,133],"Tumorsubtypen":[8],"zeigen":[9],"ein":[10,44,84,173,217],"unterschiedliches":[11],"Ansprechen":[12],"auf":[13,24],"verf\u00fcgbare":[14],"Therapien.":[15],"BRCA1-defiziente":[16,160,181],"Brusttumoren":[17,56,92,104,231],"weisen":[18],"im":[19,112,183],"Allgemeinen":[20],"einen":[21,142],"basalen":[22],"Subtyp":[23],"sind":[26],"mit":[27,49,60],"einer":[28,50],"schlechten":[29],"\u00dcberlebensrate":[30],"assoziiert,":[31],"welches":[32],"effektivere":[34],"zielgerichtete":[35],"Therapie":[36,90],"notwendig":[37],"macht.":[38],"Materialien":[39],"Methoden:":[41],"Wir":[42],"haben":[43,76],"Mausmodel":[45],"f\u00fcr":[46,86,144,218,241],"heredit\u00e4ren":[47],"hohen":[51],"Homologie":[52],"gegen\u00fcber":[53],"humanen":[54,118],"BRCA1-defizienten":[55,103,201],"untersucht":[57],"dieses":[59],"BRCA1-profizienten":[61,186],"Kontrolltumoren":[62],"verglichen.":[63],"Um":[64],"molekularen":[66],"Mechanismen":[67],"der":[68,128,138],"raschen":[69],"Tumorprogression":[70],"BRCA1-assoziierter":[71],"Tumoren":[72,119],"besser":[73],"zu":[74,185],"verstehen,":[75],"wir":[77,157,195],"getestet,":[78],"ob":[79],"dass":[80,100,159,172,197,215],"Polycomb-Group":[81],"Protein":[82],"EZH2":[83,101,125,216,227],"Angriffsziel":[85],"neuartige":[88],"spezifische":[89],"BRCA1-defizienter":[91],"darstellt.":[93,222],"Ergebnisse:":[94],"Genexpressionsanalysen":[95],"in":[96,102,117,127,137,200,229],"diesem":[97],"Mausmodell":[98],"zeigten,":[99],"\u00fcberexprimiert":[105],"ist.":[106,205],"Immunohistochemisch":[107],"wurde":[108,170],"nachweisen,":[109,196],"dass,":[110],"wie":[111],"Mausmodell,":[113],"auch":[114,228],"EZH2-Proteinlevel":[116],"von":[120,130,163,176,226],"BRCA1-Mutationstr\u00e4gern":[121],"signifikant":[122],"erh\u00f6ht":[123],"sind.":[124,167],"Repression":[129],"Genen":[131],"involviert,":[132],"wichtige":[135],"Rolle":[136],"Zelldifferenzierung":[139],"spielen,":[140],"was":[141],"Erkl\u00e4rungsansatz":[143],"den":[145],"undifferenzierten,":[146],"aggressiven":[147,244],"Phenotyp":[148],"dieser":[149],"Tumorklasse":[150],"liefern":[151],"k\u00f6nnte.":[152],"Mit":[153],"spezifischen":[154],"Knockdown-Experimenten":[155],"konnten":[156,194],"demonstrieren,":[158],"Tumorzellen":[161,182,202],"selektiv":[162],"erh\u00f6hten":[164],"EZH2-Leveln":[165],"abh\u00e4ngig":[166],"Dar\u00fcber":[168],"hinaus":[169],"gezeigt,":[171],"chemischer":[174],"Inhibitor":[175],"EZH2,":[177],"3-deazaneplanocin":[178],"A":[179],"(DZNep),":[180],"Vergleich":[184],"Brusttumorzellen":[187],"ungef\u00e4hr":[188],"20-fach":[189],"effektiver":[190],"abt\u00f6tet.":[191],"Zusammenfassung:":[192],"Insgesamt":[193],"EZH2-\u00dcberexpression":[199],"funktionell":[203],"relevant":[204],"Die":[206],"selektive":[207,236],"Wirksamkeit":[208],"des":[209],"kleinmolekularen":[210],"Inhibitors":[211],"DZNep":[212],"zeigte":[213],"auf,":[214],"Medikamente":[219],"angreifbares":[220],"Ziel":[221],"Da":[223],"\u00dcberexpression":[225],"basal-like":[230],"evident":[232],"ist,":[233],"stellt":[234],"EZH2-Inhibition":[237],"potentielle":[239],"Behandlungsmethode":[240],"diesen":[242],"besonders":[243],"Brusttumortyp":[245],"dar.":[246]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}